CMS Updates Electronic Clinical Quality Measure Resources for the 2020 Performance Period for Eligible Professionals and Eligible Clinicians

The Centers for Medicare & Medicaid Services (CMS) has updated the list of Electronic Clinical Quality Measures (eCQMs) that are fully specified and are available to be used for the 2020 performance period in the Quality Payment Program, which were finalized in the Medicare Physician Fee Schedule (PFS) Final Rule.

The updated list of eCQMs and supporting documents can be found on the eCQI Resource Center for the following programs:

The following are changes to eCQMs available for eligible professionals and eligible clinicians for 2020 reporting:

New eCQM finalized for 2020 performance period:

CMS771v1: International Prostate Symptom Score (IPSS) or American Urological Association-Symptom Index (AUA-SI) Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia

eCQMs removed from 2020 performance period:

CMS52v8: HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
CMS82v7: Maternal Depression Screening
CMS132v8: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
CMS160v8: Depression Utilization of the PHQ-9 Tool

These changes are reflected in updated links to measure specifications and supporting documents posted on the eCQI Resource Center.

Please also refer to Appendix 1: Finalized MIPS Quality Measures of the CY 2020 PFS Final Rule for a complete list of new measures (Table Group A), finalized quality measure specialty sets (Table Group B), measures finalized for removal (Table Group C), and measures finalized with substantive changes (Table Group D) for the 2020 performance period. Furthermore, please note that measures with substantive changes may have changes to benchmarks for 2020. We recommend reviewing these changes in the 2020 Quality Benchmarks file, which will be available on the QPP Resource Library later this Fall.